Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese Adults
NCT01086449
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Herpes Zoster
Interventions
BIOLOGICAL:
Herpes Zoster Vaccine GSK 1437173A
Sponsor
GlaxoSmithKline